You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epithelial defect

Showing 1 - 25 of 2,933
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Persistent Corneal Epithelial Defect Trial in United States (KPI-012, KPI-012 Vehicle)

Recruiting
  • Persistent Corneal Epithelial Defect
  • Louisville, Kentucky
  • +5 more
Feb 13, 2023

Persistent Corneal Epithelial Defect Trial in United States (lufepirsen, Vehicle)

Recruiting
  • Persistent Corneal Epithelial Defect
  • Pasadena, California
  • +5 more
Jul 21, 2023

Persistent Epithelial Defect Trial in Monterrey (PRP plus BCL, BCL plus PFL, Eye patch plus ocular lubricant ointment)

Recruiting
  • Persistent Epithelial Defect
  • PRP plus BCL
  • +2 more
  • Monterrey, Nuevo Leon, Mexico
    Departamento de Oftalmologia, Hospital Universitario "Dr. Jose E
May 16, 2022

Persistent Corneal Epithelial Defect Trial in Mexico City (KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75%

Recruiting
  • Persistent Corneal Epithelial Defect
  • KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid 0.75% (CMHA-S)
  • Mexico City, Chimalpopoca 14 Colonia Obrera, Mexico
    Instituto de Oftalmología Fundación Conde de Valenciana
Jul 6, 2022

Corneal Ulcer, Persistent Corneal Epithelial Defect Trial (LV-Visio-AMTRIX)

Withdrawn
  • Corneal Ulcer
  • Persistent Corneal Epithelial Defect
  • LV-Visio-AMTRIX
  • (no location specified)
Aug 2, 2022

Corneal Persistent Epithelial Defect Trial in Edgewood (NEXAGON High Dose Concentration, NEXAGON Low Dose Concentration, NEXAGON

Recruiting
  • Corneal Persistent Epithelial Defect
  • Nexagon® (lufepirsen) High Dose Concentration
  • +3 more
  • Los Angeles, California
  • +4 more
Aug 25, 2022

Corneal Epithelial Defect Trial in Riyadh (Amniotic membrane transplantation, Autologous serum/BSS 20%)

Completed
  • Corneal Epithelial Defect
  • Amniotic membrane transplantation
  • Autologous serum/BSS 20%
  • Riyadh, Saudi Arabia
    King Khaled Eye Specialist Hospital
Nov 21, 2021

Persistent Corneal Epithelial Defect Trial in Amman (Platelet Lysate)

Completed
  • Persistent Corneal Epithelial Defect
  • Platelet Lysate
  • Amman, Jordan
    Cell Therapy Center
Mar 2, 2021

Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • HIPEC
  • (no location specified)
Mar 2, 2022

Persistent Corneal Epithelial Defect Trial in United States (ST266)

Completed
  • Persistent Corneal Epithelial Defect
  • ST266
  • Indianapolis, Indiana
  • +7 more
Aug 13, 2021

Persistent Corneal Epithelial Defect Trial in United States (ST266, 0.67% Sodium Chloride Ophthalmic Solution, Open-label ST266)

Terminated
  • Persistent Corneal Epithelial Defect
  • ST266
  • +2 more
  • Dothan, Alabama
  • +30 more
Oct 24, 2022

Corneal Defect Trial in Shanghai (ZKY001 eye drops 0.3g:0.006mg, ZKY001 eye drops 0.3g:0.012mg, ZKY001 simulated eye drops)

Recruiting
  • Corneal Defect
  • ZKY001 eye drops 0.3g:0.006mg
  • +2 more
  • Shanghai, Shanghai, China
    Eye ＆ Ent Hospital of Fudan University
Sep 16, 2021

Neurotrophic Keratitis Trial in Canada (Insulin, Tarsorrhaphy)

Recruiting
  • Neurotrophic Keratitis
  • Edmonton, Alberta, Canada
  • +5 more
Feb 2, 2023

Keratoconus Trial in Worldwide (T4020, Placebo)

Completed
Has Results
  • Keratoconus
  • T4020
  • Placebo
  • Varna, Bulgaria
  • +3 more
Oct 11, 2019

Photorefractive Keratectomy Trial in Isfahan (prepared drop of medroxy progestrone acetat 1%)

Completed
  • Photorefractive Keratectomy
  • prepared drop of medroxy progestrone acetat 1%
  • Isfahan, Iran, Islamic Republic of
  • +1 more
Jul 26, 2023

Conjunctival and Scleral Avascular Lesions Trial in Tehran (Prescription of , Erythropoietin prescription)

Enrolling by invitation
  • Conjunctival and Scleral Avascular Lesions
  • Prescription of placebo
  • Erythropoietin prescription
  • Tehran, Iran, Islamic Republic of
    Ophthalmic Research center
Jul 25, 2022

Neurotrophic Keratitis Trial in United States (rhNGF 20µg/ml, Placebo)

Completed
Has Results
  • Neurotrophic Keratitis
  • rhNGF 20µg/ml
  • Placebo
  • Loma Linda, California
  • +11 more
Mar 31, 2022

Topical Insulin in Neurotrophic Keratopathy After Diabetic

Not yet recruiting
  • Corneal Ulcer
  • +2 more
  • rapid acting insulin
  • BaNHA, Egypt
    Benha University
Jul 2, 2023

Limbal Stem Cell Deficiency Trial in Boston (Biopsy to collect limbal epithelial stem cells that will be cultivated into a

Active, not recruiting
  • Limbal Stem Cell Deficiency
  • Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft
  • +2 more
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Mar 21, 2022

Periodontitis Trial in Cairo (ozonized olive oil, xenograft bone substitute)

Recruiting
  • Periodontitis
  • ozonized olive oil
  • xenograft bone substitute
  • Cairo, Egypt
    Ain Shams University
Dec 10, 2022

Limbal Stem-cell Deficiency, Congenital Aniridia Trial in Minneapolis (transplantation of a Descemet's Membrane corneal onlay,

Not yet recruiting
  • Limbal Stem-cell Deficiency
  • Congenital Aniridia
  • transplantation of a Descemet's Membrane corneal onlay, partial LSCD
  • transplantation of a Descemet's Membrane corneal onlay, total/near-total LSCD
  • Minneapolis, Minnesota
    University of Minnesota
Jun 15, 2023

Corneal Epithelial Wound Trial in Banha, BaNHA (Insulin, autologous serum (AS), conventional)

Not yet recruiting
  • Corneal Epithelial Wound
  • Banha, Kalyobeya, Egypt
  • +1 more
Apr 15, 2022

Intrabony Periodontal Defect Trial in Mansoura (Freeze-dried bone allograft combined with Enamel Matrix derivative, Freeze-dried

Recruiting
  • Intrabony Periodontal Defect
  • Freeze-dried bone allograft combined with Enamel Matrix derivative
  • Freeze-dried bone allograft
  • Mansoura, Egypt
    Mansoura University
Sep 16, 2023

Periodontitis Trial in Minya (RGD Peptide)

Completed
  • Periodontitis
  • RGD Peptide
  • Minya, Egypt
  • +1 more
Dec 7, 2022

Neurotrophic Keratopathy Trial in United States (OC-01 (varenicline) nasal spray 1.2 mg/ml, Placebo (vehicle) nasal spray)

Recruiting
  • Neurotrophic Keratopathy
  • OC-01 (varenicline) nasal spray 1.2 mg/ml
  • Placebo (vehicle) nasal spray
  • Dothan, Alabama
  • +30 more
Aug 8, 2022